TO KNOW THE EFFECT OF DRUG DEXMEDETOMEDINE ON BLOOD LOSS DURING BRAIN SURGERY IN COMPARISION TO NORMAL SALINE: A RANDOMIZED CONTROLLED TRIA
Not Applicable
- Conditions
- Health Condition 1: null- PATIENTS POSTED FOR ELECTIVE INTRACRANIAL MENINGIOMA SURGERY. OTHERWISE HEALTHY PATIENT
- Registration Number
- CTRI/2018/04/013433
- Lead Sponsor
- AIIMS NEW DELHI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 American Society of Anaesthesiologists (ASA) physical status I and II.
2 Patients aged 18-60 years scheduled for elective intracranial Meningioma surgery will be included in our study.
Exclusion Criteria
Refusal of consent
1 ASA class > III,
2 Morbid obesity,
3 Uncontrolled hypertension patients,
4 History of coronary artery disease,
5 Patients on beta blockers,
• History of chronic renal and hepatic insufficiency,
• History of heart block,
• History of allergy to Dexmedetomedine,
• Patients having pacemakers and automatic implantable cardioverter-defibrillator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effect on intraoperative blood loss in intracranial Meningioma surgery.Timepoint: From start till end of surgery.
- Secondary Outcome Measures
Name Time Method 1 To see perioperative consumption of analgesia <br/ ><br>2 Hemodynamic variations in the perioperative period.Timepoint: Till discharge from hospital.